An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease

Citation
Y. Stern et al., An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease, ARCH NEUROL, 58(3), 2001, pp. 460-465
Citations number
28
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ARCHIVES OF NEUROLOGY
ISSN journal
00039942 → ACNP
Volume
58
Issue
3
Year of publication
2001
Pages
460 - 465
Database
ISI
SICI code
0003-9942(200103)58:3<460:AIOCCO>2.0.ZU;2-W
Abstract
Background: Studies of patients meeting clinical and pathologic criteria fo r Alzheimer disease (AD) have not consistently found associations between t he presence of Lewy bodies (LBs) at postmortem examination and a higher fre quency during life of the clinical features of dementia with LBs. Objective: To evaluate the clinical correlates of LBs in patients with XD. Design and Methods: Fifty-one patients were diagnosed as having probable AD during life and met pathologic criteria for AD. Semiquantitative ratings f or LBs were obtained in 4 brain regions: substantia nigra, cingulate, insul ar cortex, and hippocampus. The patients had been followed up semiannually for up to 9.9 years before death, and clinical features associated with dem entia with LBs, including extrapyramidal signs and visual hallucinations, w ere assessed at each study visit. logistic regression analyses determined w hether patients who had LBs were more likely than those without LBs to expr ess specific clinical signs during follow-up. Cox analyses determined wheth er patients with LBs developed clinical signs or died earlier. Generalized estimating equations were used to compare rates of cognitive or functional change. Results: Nineteen of the 51 patients had at least 1 LB in one of the studie d regions. In no case was a significant relation noted between LBs and the presence of a measured clinical sign. No LB measure was associated with an increased risk of developing any of the evaluated clinical signs earlier in the disease. There was no association between the presence of LBs and more rapid mortality or more rapid disease progression. Conclusions: In patients diagnosed as having AD during life, we did not obs erve a relation of LBs noted during postmortem examination with the presenc e of any clinical feature that we assessed or with the rapidity of disease progression. The relation between LBs and specific clinical manifestations may be tenuous in these patients.